|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.442
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.371
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.319
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.297
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.269
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.247
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.233
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.232
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.225
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.215
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.209
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.208
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.202
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.188
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.174
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.174
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.170
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.165
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.160
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.157
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.154
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.151
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.148
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.147
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.134
|
|
|
|
positive regulation of lymphocyte apoptotic process
|
GO:0070230 |
13 |
0.128
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.125
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.124
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.124
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.121
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.120
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.120
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.120
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.118
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.115
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.114
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.113
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.112
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.111
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.111
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.110
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.108
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.107
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.105
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.104
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.103
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.103
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.102
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.102
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.100
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.099
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.098
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.098
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.098
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.097
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.095
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.095
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.094
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.094
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.093
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
23 |
0.092
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.091
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.091
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.090
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.090
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.088
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.087
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.086
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.086
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.085
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.083
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.083
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.083
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.082
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.082
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.081
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.081
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.081
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.078
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.076
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.076
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.074
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.073
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.072
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.072
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.072
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.071
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.071
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.071
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.071
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.071
|
|
|
|
muscle atrophy
|
GO:0014889 |
3 |
0.070
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.070
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.069
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.069
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.068
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.068
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.068
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.068
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.066
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.065
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.065
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.065
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.064
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.064
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.064
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.063
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.063
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.062
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.062
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.062
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.061
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.061
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.061
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.061
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.059
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.059
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.059
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.059
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.058
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.057
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.057
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.057
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.057
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.056
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.056
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.055
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.054
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.054
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.054
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.054
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.054
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.053
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.053
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.052
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.052
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.052
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.052
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.052
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.051
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.051
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.051
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.051
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.051
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.050
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.050
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.050
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.049
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.049
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.049
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.048
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.048
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.048
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.047
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.047
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.047
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.047
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.046
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.046
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.046
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.046
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.045
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.045
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.045
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.044
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.044
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.044
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.043
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.043
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.043
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.042
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.042
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.042
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.041
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.041
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.041
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.041
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.041
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.040
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.040
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.040
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.040
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.040
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.039
|
|
|
|
positive regulation of protein acetylation
|
GO:1901985 |
9 |
0.039
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.039
|
|
|
|
regulation of t cell apoptotic process
|
GO:0070232 |
28 |
0.039
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.039
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.039
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.039
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.038
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.038
|
|
|
|
negative regulation of dna binding
|
GO:0043392 |
20 |
0.038
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.038
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.038
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.038
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.037
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.037
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.037
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.037
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.037
|
|
|
|
detection of light stimulus
|
GO:0009583 |
25 |
0.036
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.036
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.036
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.036
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.036
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.036
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.035
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.035
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.035
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.035
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.035
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.035
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.034
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.034
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.034
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.034
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.034
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.034
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.034
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.034
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.034
|
|
|
|
positive regulation of epithelial to mesenchymal transition
|
GO:0010718 |
13 |
0.034
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.034
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.034
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.033
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.033
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.033
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.033
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.033
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.033
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.033
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.033
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.032
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.032
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.032
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.032
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.032
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.032
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.032
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.032
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.032
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.032
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.032
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.031
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.031
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.031
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.031
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.031
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.031
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.031
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.031
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.031
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.031
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.031
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.031
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.031
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.031
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.031
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.031
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.031
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.030
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.030
|
|
|
|
regulation of odontogenesis
|
GO:0042481 |
18 |
0.030
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.030
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.030
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.030
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.030
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.030
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.029
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.029
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.029
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.029
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.029
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.029
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.029
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.029
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.029
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.029
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.029
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.029
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.029
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.029
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.028
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.028
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.028
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.028
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.028
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.027
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.027
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.027
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.027
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.027
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.027
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.027
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.027
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.027
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.027
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.027
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.027
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.027
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.027
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.027
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.027
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.027
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.026
|
|
|
|
mammary gland branching involved in thelarche
|
GO:0060744 |
6 |
0.026
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.026
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.026
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.026
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.026
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.026
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.026
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.026
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.026
|
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.026
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.026
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.026
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.026
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.026
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.025
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.025
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.025
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.025
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.025
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.025
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.025
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.025
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.025
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.025
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.024
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.024
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.024
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.024
|
|
|
|
regulation of multicellular organismal metabolic process
|
GO:0044246 |
14 |
0.024
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.024
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.024
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.024
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.024
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.024
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.024
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.024
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.024
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.024
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.024
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.023
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.023
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.023
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.023
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.023
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.023
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.023
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.023
|
|
|
|
branch elongation of an epithelium
|
GO:0060602 |
19 |
0.023
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.023
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.023
|
|
|
|
positive regulation of t cell apoptotic process
|
GO:0070234 |
8 |
0.023
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.023
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.023
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.023
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.023
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.023
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.023
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.022
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.022
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.022
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.022
|
|
|
|
detection of visible light
|
GO:0009584 |
14 |
0.022
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.022
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.022
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.022
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.022
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.022
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.022
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.022
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.022
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.022
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.022
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.022
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.022
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.022
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.022
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.022
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.022
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.022
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.022
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.022
|
|
|
|
hematopoietic stem cell proliferation
|
GO:0071425 |
13 |
0.022
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.022
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.022
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.021
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.021
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.021
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.021
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.021
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.021
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.021
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.021
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.021
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.021
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.021
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.021
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.021
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.021
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.021
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.021
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.021
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.021
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.021
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.021
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.021
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.021
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.021
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.020
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.020
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.020
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.020
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.020
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.020
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.020
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.020
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.020
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.020
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.020
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.020
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.020
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.020
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.020
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.020
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.019
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.019
|
|
|
|
motor neuron migration
|
GO:0097475 |
4 |
0.019
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.019
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.019
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.019
|
|
|
|
axis elongation
|
GO:0003401 |
30 |
0.019
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.019
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.019
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.019
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.019
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.019
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.019
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.019
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.019
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.019
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.019
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.019
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.019
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.019
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.019
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.019
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.018
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.018
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.018
|
|
|
|
otic placode formation
|
GO:0043049 |
1 |
0.018
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.018
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.018
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.018
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.018
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.018
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.018
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.018
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.018
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.018
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.018
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.018
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.018
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.018
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.018
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.018
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.018
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.018
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.018
|
|
|
|
face development
|
GO:0060324 |
38 |
0.018
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.018
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.018
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.018
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.018
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.018
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.017
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.017
|
|
|
|
eating behavior
|
GO:0042755 |
15 |
0.017
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.017
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.017
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.017
|
|
